Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TSP Crosser Transseptal Access System

K-Number: K181088 · 2018-09-28

Decision Date2018-09-28
Product CodeDYB
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

TSP Crosser Transseptal Access System is the device name listed in this FDA 510(k) record. The listed applicant is Transseptal Solutions , Ltd.. It received FDA 510(k) clearance on 2018-09-28 under 510(k) number K181088. The device is classified under product code DYB. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TSP Crosser Transseptal Access System?

TSP Crosser Transseptal Access System is a medical device that received FDA 510(k) clearance on 2018-09-28. The listed applicant is Transseptal Solutions , Ltd.. The 510(k) number is K181088.

When did TSP Crosser Transseptal Access System receive FDA 510(k) clearance?

TSP Crosser Transseptal Access System received FDA 510(k) clearance on 2018-09-28, under 510(k) number K181088.

Who is the listed applicant for TSP Crosser Transseptal Access System?

The FDA 510(k) record lists Transseptal Solutions , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TSP Crosser Transseptal Access System?

The FDA product code for TSP Crosser Transseptal Access System is DYB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: DYB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.